Same lehenga, 3 looks feat. Isha Ambani

Isha Ambani is a fashion enthusiast and has an impeccable collection of ethnic outfits.

The diva, like a true fashionista, knows how to style the same outfit in different ways.

Isha Ambani showcased her styling prowess as she wore her blush pink lehenga designed by Abu Jani and Sandeep Khosla for the third time.

She recently wore it for an event in Udaipur, and teamed it with an exquisite floral choker and peacock-inspired earrings.

Isha first wore this lehenga for a family wedding in 2019.

Back then, she styled it with glamorous makeup and diamond jewellery.

In 2020, she wore the same lehenga for Armaan Jain’s wedding. She infused a pop of colour with emerald jewellery to complete the look.

It is super cool to repeat outfits, Isha Ambani knows it.




Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Another Weight Loss Drug Could Soon Join Ozempic in U.S. thumbnail

Another Weight Loss Drug Could Soon Join Ozempic in U.S.

Please enable cookies. Error 1005 Ray ID: 7d2486090a8685c6 • 2023-06-05 01:08:17 UTC What happened? The owner of this website (www.webmd.com) has banned the autonomous system number (ASN) your IP address is in (47583) from accessing this website. Was this page helpful? Thank you for your feedback! Cloudflare Ray ID: 7d2486090a8685c6 • Your IP: 89.117.245.16 •
Read More
מחכים ל-SpFN thumbnail

מחכים ל-SpFN

בארה"ב מתנהל כעת מחקר לפיתוח חיסון אוניברסלי לקורונה שיהיה יעיל נגד גרסאות עתידיות של הנגיף. המחקר מתקיים בשלוש אוניברסיטאות בארה"ב, וצבא ארה"ב השלים לאחרונה ניסוי שלב 1 של חיסון אוניברסלי לקורונה משלו. לדברי מומחים שצוטטו השבוע באתר החדשות CNET, סוגי החיסונים שנמצאים בפיתוח עשויים לעזור גם נגד מחלות נגיפיות אחרות כמו שפעת ואבולה. לצד היעילות…
Read More
Kids With MS May Have Better Outcomes When Started on High-Efficacy Treatment Early thumbnail

Kids With MS May Have Better Outcomes When Started on High-Efficacy Treatment Early

Meeting Coverage > ECTRIMS — Starting monoclonal antibody therapy during childhood reduced long-term disability by Judy George, Deputy Managing Editor, MedPage Today September 20, 2024 Starting high-efficacy monoclonal antibody therapy during childhood reduced long-term disability in pediatric-onset multiple sclerosis (MS), registry data suggested. Among 282 patients with pediatric-onset MS, 39% started high-efficacy therapy early (at
Read More
WHO/Europe launches New Economics Expert Group to advance health equity thumbnail

WHO/Europe launches New Economics Expert Group to advance health equity

WHO/Europe, through the WHO European Office for Investment for Health and Development, based in Venice, Italy, has launched a New Economics Expert Group (NEEG) comprised of representatives and research specialists from 14 institutions. The group will work to facilitate the implementation of the WHO resolution on accelerating progress towards healthy, prosperous lives for all in…
Read More
Optimizing Digital Patient Experience; Prescribing Nature to Patients? thumbnail

Optimizing Digital Patient Experience; Prescribing Nature to Patients?

Welcome to this week's edition of Healthcare Career Insights. This weekly roundup highlights healthcare career-related articles culled from across the Web to help you learn what's next.Will telehealth advancements survive beyond the pandemic? – Pressure mounts on Congress to enact telehealth reform (Medical Economics)Taking your patient experience online – 4 ways to optimize the digital…
Read More
Index Of News
Total
0
Share